Nachrichten zur Merck & Co. Inc. Aktie

Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales

Merck (MRK) beats first-quarter estimates for earnings and sales. The company raises its EPS range for 2024. Stock rises in…

4 Large Drug Stocks to Hold on to Amid Industry Challenges

Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk…

AKTIEN IM FOKUS: US-Konkurrent Danaher schiebt Merck KGaA und Sartorius an

FRANKFURT/NEW YORK (dpa-AFX) - Der US-Konzern Danaher hat mit überraschend guten Quartalszahlen am hiesigen Aktienmarkt auch bei den Anlegern…

How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?

Investor focus is likely to be on the sales of Mercks (MRK) blockbuster oncology medicine, Keytruda, when the company reports…

Merck: Kursziel 200 Euro bestätigt - Ist das die Einstiegschance?

Merck-Aktien ISIN: DE0006599905 gehören in der vergangenen Handelswoche mit knapp 5 Prozent minus zu den größten Verlierern im DAX. Nach…

Cramer’s week ahead: Earnings from Tesla, Merck and Big Tech

CNBCs Jim Cramer said next weeks PCE index report will be the real gauge of inflation.…

Global CAR T-Cell Therapy Market Size To Worth USD 21.92 Billion By 2033 | CAGR of 17.72%

The Global CAR T-Cell Therapy Market Size was Valued at USD 4.29 Billion in 2023 and the Worldwide CAR T-Cell…

Better Growth Play: Merck or The Vanguard Growth Index Fund?

Mercks shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?…

Better Growth Play: Merck or The Vanguard Growth Index Fund? @themotleyfool #stocks $MRK $LLY $^GSPC $PFE $BMY $GILD $NVO $VUG

Mercks shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?…

Merck Paid $208 Million to Stop Its Drugs From Working. Heres Why Thats Bullish.

Being able to stop a drugs unwanted effects could lead to a larger market share.…

Merck, Vertex could beat expectations despite more subdued 1Q biopharma earnings anticipated: BofA

US biopharma companies may see more subdued first-quarter earnings due to the typical seasonality across the sector and new healthcare plan...…

1 New Green Flag for Moderna and Merck Stock

Theres a new reason to believe that their joint projects are going well.…

Cardinal Health, Cigna, Merck among top healthcare Quant picks ahead of Q1 earnings

…

Krebs-Impfstoff: Moderna-Daten lösen Kurssprung aus

Nach BioNTech am Wochenende überrascht auch Moderna mit vielversprechenden Daten eines Krebsimpfstoffes. Insbesondere in Kombination mit einem zugelassenen Präparat des…

Merck & Co: Umsatzprognose für Winrevair erhöht - Aktienanalyse

Hamburg (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Berenberg: Die Analysten von Berenberg stufen die Aktie von Merck & Co Inc. (ISIN:…

Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)

Mercks (MRK) phase II/III study called REJOICE-Ovarian01 study will evaluate the efficacy of raludotatug deruxtecan in patients with platinum-resistant ovarian…

Merck (MRK) Begins Phase III NSCLC Study on KRAS Candidate

Mercks (MRK) phase III study will evaluate KRAS G12C inhibitor candidate MK-1084 for first-line treatment of certain patients with metastatic…

Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III

FDA approves AstraZenecas (AZN) Voydeya (danicopan) in the United States as add on therapy to its other C5 inhibitors. Merck…

Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug

Mercks (MRK) phase II/III study called REJOICE-Ovarian01 study will evaluate the efficacy of raludotatug deruxtecan in patients with platinum-resistant ovarian…

Merck: We Were Wrong, But The Exuberance Is Overly Done Here (Rating Upgrade)

…

Merck & Co: Kursziel angehoben

Charlotte, NC (www.aktiencheck.de) - Rating-Update: Robyn Karnauskas, Analystin von Truist, stuft die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN:…

Von Biotech zu Techbio: Diese Pharma-Pläne haben die KI-Partner von Bayer, Merck und Co.

Immer mehr Tech-Unternehmen entwickeln mit Unterstützung von Künstlicher Intelligenz eigene Medikamentenkandidaten. Aber der Beweis, wie gut die Wirkstoffe wirklich sind,…

Merck: Better Times Ahead On Approvals And Outlook

…

Merck CEO on Winrevair Approval, Obesity Drug, Health Costs

Merck Chair and CEO Robert M. Davis discusses the US approval of Winrevair, a new treatment for a rare, dangerous…

Merck: Kursziel erhöht

San Francisco (www.aktiencheck.de) - Rating-Update: Die Analysten von Wells Fargo Advisors bewerten die Aktie von Merck & Co Inc. (ISIN: US58933Y1055,…

Stock market today: World shares are mostly higher after S&P 500 sets another record

European shares have opened higher after a mixed trading session in Asia. Chinese markets rose and Tokyos benchmark fell. Oil…

Pharma Stock Roundup: ABBV & NVOs New M&As, FDA Nod to JNJ & MRK PAH Drugs

While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves…

[Latest] Global PARP Inhibitors Market Size/Share Worth USD 23.5 Billion by 2032 at a 12.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

Mercks Future Brightens With Winrevairs Blockbuster Potential

…

Stocks making the biggest moves midday: GameStop, Merck, Carnival, Cintas and more

These are the stocks posting the largest moves in midday trading.…

Merck shares move higher as lung disorder drug secures ‘squeaky clean’ label from FDA

Merck & Co Inc (NYSE:MRK, ETR:6MK) shares traded more than 4% higher after it won US Food and Drug Administration…

Stocks making the biggest moves premarket: Robinhood, GameStop, Merck and more

These are the stocks posting the largest moves in premarket trading.…

GameStop falls premarket; Merck, Robinhood and Moderna rise By Investing.com

GameStop falls premarket; Merck, Robinhood and Moderna rise…

Merck & Co: Die Zulassung eines vielversprechenden Medikaments - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Merck & Co-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Merck &…

5 Things to Know Before the Stock Market Opens

GameStop’s earnings disappoint investors, Robinhood Markets’ credit card launch is well received, Trump Media & Technology Group shares are rising…

Merck (MRK) Gets FDA Approval for New PAH Drug Winrevair

Mercks (MRK) Winrevair becomes the first novel activin signaling inhibitor approved by the FDA to treat PAH.…

Merck hits record high after FDA approves lung disease drug By Investing.com

Merck hits record high after FDA approves lung disease drug…

Merck bekommt FDA-Zulassung für Sotatercept - Aktie zieht an

WASHINGTON (dpa-AFX) - Die Genehmigung eines mit hohen Erwartungen verknüpften Medikaments hat den Aktienkurs des US-Pharmakonzerns Merck & Co im…

Merck bekommt FDA-Zulassung für Sotatercept - Aktie zieht an

WASHINGTON (dpa-AFX) - Die Genehmigung eines mit hohen Erwartungen verknüpften Medikaments hat den Aktienkurs des US-Pharmakonzerns Merck & Co …

Merck bekommt FDA-Zulassung für Sotatercept - Aktie zieht an

WASHINGTON (dpa-AFX) - Die Genehmigung eines mit hohen Erwartungen verknüpften Medikaments hat den Aktienkurs des US-Pharmakonzerns…

Merck bekommt FDA-Zulassung für Sotatercept - Aktie zieht an

WASHINGTON (dpa-AFX) - Die Genehmigung eines mit hohen Erwartungen verknüpften Medikaments hat den Aktienkurs des US-Pharmakonzerns Merck & Co (Merck)…

FDA approves Mercks drug for rare, deadly lung condition

The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug…

US FDA approves Mercks blood pressure therapy By Reuters

US FDA approves Mercks blood pressure therapy…

After-hours movers: Merck, GameStop, Shockwave Medical, and more By Investing.com

After-hours movers: Merck, GameStop, Shockwave Medical, and more…

Mercks (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study

Mercks attempt to use the Keytruda-Lynparza combination in certain non-small cell lung cancer patients has come up short with a…

Merck: Doppelte Hochstufung der Aktie

Merck hat die eigene Prognose für 2023 erfüllt. Gemeldet wird ein Umsatz von 21,0 Milliarden Euro, die Prognose lag bei…

Top Research Reports for JPMorgan Chase, Merck & SAP

Todays Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Merck & Co.,…

Merck: 200 oder 172 Euro? Alle Kursziele und Ratings nach Q4-Zahlen auf einen Blick - Aktiennews

Darmstadt (www.aktiencheck.de) - Welche Kursziele und Ratings trauen die Analysten der führenden Banken und Research-Häuser der Merck-Aktie (ISIN: DE0006599905, WKN:…

Pharmaunternehmen : Neue KI-Anwendung verändert den Arbeitsalltag von Tausenden Mitarbeitern

Merck hat einen eigenen KI-Assistenten entwickelt. Die Beschäftigten sollen dadurch Zeit sparen und ihre Arbeit optimieren. Der Konzern geht damit…

Merck & Co., Inc. (MRK) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)

…